These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7723953)

  • 1. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.
    Goetz CG; Stebbins GT
    Neurology; 1995 Apr; 45(4):669-71. PubMed ID: 7723953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for nursing home placement in advanced Parkinson's disease.
    Goetz CG; Stebbins GT
    Neurology; 1993 Nov; 43(11):2227-9. PubMed ID: 8232934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.
    Aarsland D; Larsen JP; Tandberg E; Laake K
    J Am Geriatr Soc; 2000 Aug; 48(8):938-42. PubMed ID: 10968298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study.
    Bjornestad A; Pedersen KF; Tysnes OB; Alves G
    Parkinsonism Relat Disord; 2017 Sep; 42():28-33. PubMed ID: 28578818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal outcome of Parkinson's disease patients with psychosis.
    Factor SA; Feustel PJ; Friedman JH; Comella CL; Goetz CG; Kurlan R; Parsa M; Pfeiffer R;
    Neurology; 2003 Jun; 60(11):1756-61. PubMed ID: 12796526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive correlates of hallucinations and delusions in Parkinson's disease.
    Factor SA; Scullin MK; Sollinger AB; Land JO; Wood-Siverio C; Zanders L; Freeman A; Bliwise DL; McDonald WM; Goldstein FC
    J Neurol Sci; 2014 Dec; 347(1-2):316-21. PubMed ID: 25466695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.
    Pagonabarraga J; Martinez-Horta S; Fernández de Bobadilla R; Pérez J; Ribosa-Nogué R; Marín J; Pascual-Sedano B; García C; Gironell A; Kulisevsky J
    Mov Disord; 2016 Jan; 31(1):45-52. PubMed ID: 26408291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease and nursing home placement: the economic impact of the need for care.
    Vossius C; Nilsen OB; Larsen JP
    Eur J Neurol; 2009 Feb; 16(2):194-200. PubMed ID: 19146640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of visual hallucinations in patients with Parkinson's disease.
    Klein C; Kömpf D; Pulkowski U; Moser A; Vieregge P
    J Neurol; 1997 Jun; 244(6):371-7. PubMed ID: 9249622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease.
    Pacchetti C; Manni R; Zangaglia R; Mancini F; Marchioni E; Tassorelli C; Terzaghi M; Ossola M; Martignoni E; Moglia A; Nappi G
    Mov Disord; 2005 Nov; 20(11):1439-48. PubMed ID: 16028215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients.
    Hepp DH; da Hora CC; Koene T; Uitdehaag BM; van den Heuvel OA; Klein M; van de Berg WD; Berendse HW; Foncke EM
    Parkinsonism Relat Disord; 2013 Sep; 19(9):795-9. PubMed ID: 23706540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychotic symptoms in Parkinson's disease].
    Fénelon G
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4 Spec No 1():S17-24. PubMed ID: 23631044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of hallucinations in Parkinson's disease using a novel scale.
    Wada-Isoe K; Ohta K; Imamura K; Kitayama M; Nomura T; Yasui K; Nakaso K; Nakashima K
    Acta Neurol Scand; 2008 Jan; 117(1):35-40. PubMed ID: 18095953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early dopaminergic drug-induced hallucinations in parkinsonian patients.
    Goetz CG; Vogel C; Tanner CM; Stebbins GT
    Neurology; 1998 Sep; 51(3):811-4. PubMed ID: 9748031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.
    Sinforiani E; Pacchetti C; Zangaglia R; Pasotti C; Manni R; Nappi G
    Mov Disord; 2008 Jul; 23(10):1441-5. PubMed ID: 18512749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surviving 10 years with deep brain stimulation for Parkinson's disease--a follow-up of 79 patients.
    Bang Henriksen M; Johnsen EL; Sunde N; Vase A; Gjelstrup MC; Østergaard K
    Eur J Neurol; 2016 Jan; 23(1):53-61. PubMed ID: 25492023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.
    Hely MA; Morris JG; Traficante R; Reid WG; O'Sullivan DJ; Williamson PM
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):300-7. PubMed ID: 10449550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of associated clinical variables and phenomenology of hallucinations in Parkinson's].
    Cubo E; González M; Aguilar A; Quintana S
    Neurologia; 2006; 21(1):12-8. PubMed ID: 16525921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease.
    Papapetropoulos S; Katzen H; Schrag A; Singer C; Scanlon BK; Nation D; Guevara A; Levin B
    BMC Neurol; 2008 Jun; 8():21. PubMed ID: 18570642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.